Analyst Price Targets — IQV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 11:43 am | Ann Hynes | Mizuho Securities | $230.00 | $207.85 | TheFly | Iqvia price target raised to $230 from $215 at Mizuho |
| July 9, 2026 12:33 pm | — | Deutsche Bank | $240.00 | $208.00 | TheFly | Iqvia named short-term buy idea at Deutsche Bank |
| July 6, 2026 2:22 pm | Sidharth Sahoo | HSBC | $240.00 | $206.42 | TheFly | Iqvia price target raised to $240 from $210 at HSBC |
| July 1, 2026 10:31 am | — | Robert W. Baird | $249.00 | $193.22 | TheFly | Iqvia price target raised to $249 from $230 at Baird |
| June 17, 2026 10:31 am | Kallum Titchmarsh | Morgan Stanley | $200.00 | $179.17 | TheFly | Iqvia downgraded to Equal Weight from Overweight at Morgan Stanley |
| June 3, 2026 9:27 am | — | HSBC | $210.00 | $180.64 | TheFly | Iqvia price target lowered to $210 from $240 at HSBC |
| May 7, 2026 1:19 pm | — | Morgan Stanley | $225.00 | $179.31 | TheFly | Iqvia price target lowered to $225 from $240 at Morgan Stanley |
| April 8, 2026 1:14 pm | Elizabeth Anderson | Evercore ISI | $185.00 | $172.54 | TheFly | Iqvia price target lowered to $185 from $225 at Evercore ISI |
| February 23, 2026 12:37 pm | — | Mizuho Securities | $215.00 | $165.62 | TheFly | Iqvia price target lowered to $215 from $266 at Mizuho |
| February 19, 2026 1:34 pm | — | Truist Financial | $245.00 | $165.64 | TheFly | Iqvia price target lowered to $245 from $290 at Truist |
Latest News for IQV
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing,…
Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.
TORONTO--(BUSINESS WIRE)--StackAdapt (www.stackadapt.com), the leading AI advertising and orchestration platform, today announced a collaboration with IQVIA Digital to advance more relevant and compliant engagement with healthcare audiences. IQVIA Digital's integrated solutions enable marketers to quickly transform data-driven insights into meaningful, privacy-conscious activation across the healthcare…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.